XML 17 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Unaudited Condensed Consolidated Balance Sheet - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Current Assets:    
Cash and cash equivalents $ 85,593 $ 40,501
Accounts receivable 0 430
Inventory 16,576 15,910
Prepaid expenses 2,406 1,255
Deposits 7,590 7,590
Total current assets 112,165 65,686
Equipment (net of $43,723 and $37,109 depreciation, respectively) 26,352 32,456
Patents (net of $58,918 amortization and $556,120 impairment) 0 0
Total assets 138,517 98,142
Current Liabilities:    
Notes payable 439,496 586,307
Notes payable - related party 128,269 129,261
Accounts payable & accrued expenses 89,883 96,882
Interest payable 28,548 21,077
Total current liabilities 686,196 833,527
Long-term portion of notes payable 63,234 0
Total liabilities 749,430 833,527
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY (DEFICIT)    
Common Stock, $0.001 per share; authorized 3,000,000,000 shares; Issued and outstanding 191,710,596 and 35,319,990 at June 30, 2020 and December 31, 2019, respectively 191,709 35,320
Capital paid in excess of par value 17,267,946 16,616,426
Accumulated comprehensive income (3,360) (2,495)
Accumulated earnings (deficit) (18,167,208) (17,434,636)
Total shareholders' equity (deficit) (610,913) (735,385)
Total liabilities and shareholders' equity 138,517 98,142
Series B Preferred Stock    
SHAREHOLDERS' EQUITY (DEFICIT)    
Preferred stock $ 100,000 $ 50,000